Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-04

Clinical Trial Update: Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders [NA]

View source ↗

Summary

A completed clinical trial update from Massachusetts General Hospital on using neuromodulation to enhance emotion regulation in bipolar disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Bipolar Disorder | NA | Status: COMPLETED